Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience.
Özbalak M, Salihoğlu A, Soysal T, Karadoğan İ, Paydaş S, Özdemir E, Yıldız B, Karadurmuş N, Kaynar L, Yagci M, Özkocaman V, Topçuoğlu P, Özcan M, Birtaş E, Göker H, Ferhanoglu B.
Özbalak M, et al. Among authors: ferhanoglu b.
Ann Hematol. 2020 Feb;99(2):301-307. doi: 10.1007/s00277-019-03899-1. Epub 2019 Dec 17.
Ann Hematol. 2020.
PMID: 31844933